RxDoctor Payments Data

Morgan Johnson

Adult Health · Nashville, TNNPI 1508098740

Payments from drug & device makers

$2,121in general payments, 2019–2025

Across 65 payments — averaging $32.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$1K
  • Boehringer Ingelheim$340
  • Abbott$156
  • Amgen$130
  • Esperion Therapeutics, Inc.$116
  • Abiomed$47
  • plus $121 from 4 others

What the payments were for

  • Consulting fees$1567%
  • Food & beverage$1,96593%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,121 in reported general payments places this provider in the 75th percentile of 352 adult health providers in Tennessee.

See all adult health providers in Tennessee

Medicare billing

Part B allowed, 2024
$84,260
Medicare patients
539
Services billed
1,142

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EntrestoSacubitril/Valsartan238$383,900
EliquisApixaban283$354,937
JardianceEmpagliflozin146$236,491
Repatha SureclickEvolocumab195$181,171
XareltoRivaroxaban50$72,226
FarxigaDapagliflozin Propanediol40$47,370
Praluent PenAlirocumab56$42,135
BrilintaTicagrelor23$19,361
OzempicSemaglutide13$12,385
Metoprolol Succinate422$6,424
Torsemide170$5,202
Prasugrel Hcl40$4,460
Atorvastatin Calcium323$3,596
Olmesartan Medoxomil130$2,546
Carvedilol277$2,433

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance$340$236,491146 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 352 adult health providers in Tennessee.

Other adult health in Nashville

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →